- Home
- MPT vs INDV Comparison
MPT vs INDV Comparison
Compare MPT & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$4.55
HOLD
Current Price
$29.00
Company Overview
Basic Information| Metric | MPT | INDV |
|---|---|---|
| Founded | 2003 | N/A |
| Country | United States | United States |
| Employees | 118 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 4.0B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | MPT | INDV |
|---|---|---|
| Price | $4.55 | $29.00 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 5.9M | 3.2M |
| Earning Date | 04-30-2026 | 06-08-2026 |
| Dividend Yield | ★ 7.07% | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | N/A | ★ 1.64 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.75 | N/A |
| P/E Ratio | ★ N/A | $18.27 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $4.51 | $8.65 |
| 52 Week High | $6.47 | $38.00 |
Technical Indicators
Market Signals| Indicator | MPT | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 31.55 | 36.62 |
| Support Level | $4.51 | $22.39 |
| Resistance Level | $5.85 | $35.75 |
| Average True Range (ATR) | 0.19 | 1.72 |
| MACD | -0.03 | -0.11 |
| Stochastic Oscillator | 3.88 | 17.59 |
Price Performance
Historical Comparison MPT
INDV
About MPT Medical Properties Trust Inc. common stock
Medical Properties Trust Inc acquires and develops net-leased healthcare facilities. Its investments in healthcare real estate, other loans, and any investments in tenants are considered a single reportable segment. The group's geographic areas are the United States, the United Kingdom, and All other countries.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease.